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BACKGROUND: In inflammatory  bowel disease ( IBD) ,
cy tokine levels ( such  as interleukin-1 ( IL-1) )  are
elevated. We have shown previously  that IL-1 activates
phospho lipid s ignaling pathways in intestinal epithe-
lial cells ( IEC) , leading to increased ceramide levels.
Aim: To  determine whether ceramide induces apopto-
sis in IEC.
Methods: Apoptosis was evaluated by  annex in-V bind-
ing or Hoechst nuclear staining. Levels o f bcl-2, bcl-x ,
bax , p53 and p21 were determined by  Western
blo tting, and cell cycle analysis was determined by
flow cytometry.
Results: IL-1 increased ceramide accumulation  in a
time-dependent and concentration-dependent man-
ner with  a peak response at 4 h , with  [IL-1] = 30 ng/ ml.
Neither IL-1 nor ceramide induced apoptosis in  IEC,
but they  increased bcl-2 levels and decreased bax  and
p21 levels without affecting bcl-x  and p53 levels. They
also  caused a slight but sign ificant increase in the
G2/ M phase. These data suggest a ro le for ceramide in
IBD and suggest a possible mechanism for the
enhanced tumorigenic activity  in IBD patients.
Key  words: Epithelial cells, IL-1, bcl-2, bcl-x, bax, IBD,
Inflammation
Introduction
Programmed cell death, apoptosis, plays a pivotal role
in the development and maintenance of homeostasis
within all multicellular organisms.1 Apoptosis can be
initiated by a variety of stimuli depending on the cell
type and on the subcellular component targeted by
each type of stimulant.
The sphingomyelin (SM) signal transduction path-
way has been shown to mediate apoptosis through
several cell surface receptors and environmental
stresses.2,3 The SM pathway is a ubiquitous signaling
system in which ceramide plays a central role.
Ceramide has been implicated in a variety of cellular
processes from cell growth and differentiation and
gene transcription to cell death.4,5 Many receptors,
such as interleukin-1 (IL-1) and tumor necrosis factor-
a (TNF-a), transduce their signal via the SM path-
way.4,6 In inflammatory bowel disease (IBD), which
includes ulcerative colitis and Crohn’s disease, the
levels of the cytokine IL-1 levels have been shown to
be significantly increased due to the infiltration of
inflammatory cells into the intestinal mucosa. We
have recently shown that IL-1 causes significant
accumulation in ceramide levels in intestinal epithe-
lial cells and that both ceramide and IL-1 increase
prostaglandin E2 (PGE2) production through inducing
cyclooxygenase-2 (COX-2) synthesis,6,7 a major reg-
ulator of chloride secretion. This increase in PGE2
levels contributes significantly to the rise in chloride
and water secretion observed in IBD patients.
Colorectal cancer represents the major cause for
increased morbidity and mortality by malignant dis-
ease in inflammatory bowel disease.8 Alterations in
the level of expression of many proto-oncogenes,
such as c-yes, c-fos and c-abl, or expression of
aberrant gene productions have been observed in
tumors and pre-cancerous conditions.9 Specifically,
however, c-yes-enhanced expression in IBD patients
with tumors suggests the importance of this gene in
the development of colon cancer in IBD.9 Increased
tumor formation could be attributed to the increased
resistance of intestinal cells to apoptosis. Studies in rat
intestinal epithelial cells have shown that over-
expression of COX-2 leads to phenotypic changes in
these cells that would enhance their tumorigenic
potential. The cells were resistant to apoptosis and
had elevated bcl-2 protein expression, both of which
were reversed when the cells were treated with a
COX-2 inhibitor.10
Although the capacity to carry out apoptosis
appears to be inherent to all cells, the susceptibility to
apoptosis varies markedly and is influenced by
external and cell-autonomous events. The bcl-2 family
of proteins constitutes a critical intracellular check-
point of apoptosis within a distal common cell death
pathway. Over-expression of bcl-2 prolonged cell
survival of interleukin-3-dependent pro-B-cell lines
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and promyeloid cell lines, and maintained the cells in
G0.
11 bcl-2 was also capable of protecting T cells
against a variety of apoptotic signals, including
glucocorticoids, g-irradiation and phorbal esters.12,13
Over-expression of bax protein, on the contrary, leads
to accelerated apoptotic death in response to a death
signal, giving bax its designation as a death agonist.
The ratio of bcl-2 to bax is important in determining
susceptibility to apoptosis.14
In the present study, the effect of elevating ceramide
levels, either through IL-1 receptors or by the
exogenous addition of membrane-permeable synthetic
ceramide, on apoptosis in intestinal epithelial cells was
assessed and their effect on the levels on regulators of
apoptotic pathway and on cell cycle phases studied.
We present evidence that supports the hypothesis that
chronic inflammation of the mucosa in the absence of
apoptosis may explain the increased propensity of IBD
patients to colorectal cancers.
Materials and methods
Materials
Human recombinant IL-1a was a generous gift from
Immunex (Seattle, WA, USA). The ECL protein
detection kit and PVDF membrane were from Amer-
sham (Amersham, Bucks, UK). Fetal bovine serum
(FBS) and bovine serum albumin, penicillin and
streptomycin, Dulbecco’s Modified Eagle’s Medium
(DMEM), F-12 medium, pyruvate, non-essential amino
acids, goat serum and Earl’s balanced salt solution
were from Gibco Laboratories (Paisley, UK). Acryla-
mide, N9,N9-bis-methylene-acrylamide, sodium dode-
cyl sulfate (SDS), glycine, tris, glycerol, 2-b-mercapto-
ethanol, ammonium persulfate, N,N,N ’,N ’-tetra-
methylethylenediamine (TEMED), chloroform, ethyle-
nediamine tetraacetic acid, ethylene glycol-bis(b-
aminoethylether)-N,N,N ’,N ’-tetraacetic acid (EGTA),
methanol, acetic acid, isopropanol, dithiothreitol,
imidazole, LiCl, and camptothecine were from Sigma
(St Louis, MO, USA). Annexin-V was from Boehringer
Mannheim (Mannheim, Germany), and Hoechst
nuclear stain was from Molecular Probes (Portland,
OR, USA). Mouse antisera to p53, bcl-2, bcl-x and bax
were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Mouse antiserum to p21
(WAF1) were obtained from Oncogene Research
Products (Calbiochem, San Diego, CA, USA), and
mouse antibodies to poly(adenosine diphosphate-
ribose) polymerase (PARP) were obtained from
Enzyme Systems products (Livermore, CA, USA).
Membrane-permeable C2-ceramide was obtained
from BioMol (Plymouth Meeting, PA, USA). COX-2
inhibitor L-745,337 (5-methanesulfonamide-
6-(2,4-difluorothiophenyl)-1-indanone), was a gener-
ous gift from the Merck Frosst Center for Therapeutic
Research, Quebec, Canada.
Cell culture
Murine small intestinal epithelial cells (IEC), line
Mode-K,15 were obtained from Dr P.B. Ernst (Uni-
versity of Texas, Medical Branch, Galveston, TX, USA).
Mode-K cells were maintained in DMEM (low glu-
cose) containing 10% FBS, 10 mM sodium pyruvate,
and non-essential amino acids. T-84 cells, human
colonic cell line, were grown in DMEM/F-12 medium
supplemented with 10% FBS. Cell viability was
measured using the trypan blue exclusion assay. An
increase in trypan blue positive cells could represent
increased cellular necrosis or late changes in cell
permeability secondary to apoptosis.
Cells were trypsinized, centrifuged at 200 ´ g, and
washed in phosphate-buffered saline (PBS) twice. The
cells were then resuspended in PBS : 2x electrophore-
sis sample buffer, ratio 1 : 1. The sample buffer
consisted of 0.25 M Tris–HCl (pH 6.8), 4% w/v SDS,
20% v/v glycerol and 0.1% bromophenol blue. Samples
were then boiled for 5 min and stored at –80°C.
Measurement of ceramide levels
Lipids were extracted from cells according to the
method of Bligh and Dyer.16 In brief, cell suspensions
were washed with PBS and the organic and aqueous
phases were separated by chloroform and water.
Ceramide levels were measured in the dried samples
using a modified diacylglycerol kinase assay.17,18
Samples were solubilized in octyl-b-D-glucoside/dio-
leoyl phosphatidylglycerol micellar solution
(7.5%/25 mM). To the lipid micelles, diglycerol kinase
and [g32P]adenosine triphosphate were added. Sam-
ples were then extracted and lipids were spotted on a
silica gel thin-layer chromatography plate. Plates were
developed with chloroform/acetone/methanol/acetic
acid/water (50 : 20 : 15 : 10 : 5), air dried and
subjected to autoradiography. The radioactive spots
corresponding to ceramide phosphate were scraped
into scintillation vials and the 32P activity counted in
a scintillation counter. Ceramide levels were normal-
ized to lipid phosphate. To measure lipid phosphate,
samples were oxidized with 150ml of 70% perchloric
acid at 180°C for 1 h. Phosphate levels were measured
by the addition of ammonium molybdate and ascorbic
acid, and the absorbance read at 820 nm.
Polyacrylamide gel electrophoresis and
Western blot analysis
Approximately 30mg of proteins obtained from cell
homogenates from various treatments were loaded
onto a 12% SDS-polyacrylamide gel, subjected to
electrophoresis, blotted onto nitrocellulose mem-
brane, and blocked in 5% non-fat milk containing 0.1%
Tween 20 in Tris-buffered saline for 1.5 h. The blots
were incubated with the appropriate antibody at 4°C
in 1% tris-buffered saline (TWEEN), washed and
reacted with horseradish peroxidase-conjugated
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secondary antibody. The protein bands were detected
with chemoluminescence utilizing the ECL detection
method and were quantified using ImageQuant soft-
ware and the Molecular Dynamics Storm 860 System
(Molecular Dynamics, Sunnyvale, CA, USA).
Apoptosis studies
IEC apoptosis was induced with various agents and
assessed by annexin-V binding using flow cytometry
or by Hoechst nuclear staining using fluorescence
microscopy. Apoptosis was induced by either one of
the following conditions.
1. Cells were exposed to either ultraviolet (UV)
50–60 mJ/cm2 using a F5–10 T12 lamp (Westing-
house sunlamp tube (Lighting Supplies, Canton,
OH, USA); emission, 313 nm) or to g-irradiation
energy at 527 rad/min using 137Cs as a source.
Both treatments have been shown to cause DNA
damage and to mediate radiation-induced cell
apoptosis through the p53-dependent pathway.19
2. Cells were treated with 1mM camptothecin for
24 h or with 1 mM H2O2 for 2 h as positive
controls. Camptothecin is an anti-cancer agent,
which inhibits DNA topo-isomerase I activity and
causes DNA double-strand breaks during DNA
replication to induce S-phase-dependent apopto-
sis,20 while H2O2 induces apoptosis possibly
through activation of p53.21
The ability of IL-1 or ceramide to induce apoptosis in
Mode-K cells was assessed by treating the cells with
30 ng/ml of IL-1 or with 30mM ceramide, or their
combination, for periods ranging from 2 to 24 h.
For annexin V binding, 106 cells were washed in
PBS, pelleted at 200 ´ g for 5 min, and then incubated
with FITC-conjugated Annexin-V in the presence of
1 mM CaCl2. Nuclei of necrotic cells were counter
stained with propidium iodide (PI) (50mg/ml) for
10 min at room temperature, and cells were screened
by flow cytometry using Cell Quest software (approx-
imately 10,000 events). Apoptosis was estimated by
the relative amount of FITC-positive/PI-negative cell
populations. For Hoechst staining, cells were cultured
on coverslips to around 80% confluent. After the
different treatments, cells were washed three times
with PBS for 10 min and then incubated with Hoechst
stain #33342 (2mg/ml) for 20 min, washed again in
PBS three times for 10 min and fixed in formaldehyde
(4%), and observed under a fluorescence microscope.
Apoptotic cells were recognized by the typical
appearance of condensed chromatin in the nucleus
and apoptotic bodies.
Cell cycle analysis
Cells were harvested at pre-determined time-points
after treatment, washed twice with cold PBS and fixed
in methanol (–20°C). Subsequently, cells were rinsed
with PBS, treated with Tris–HCl buffer (pH 7.4)
containing 1% RNase and stained with PI (final
concentration, 50mg/ml). Cells were centrifuged and
resuspended in 4% formaldehyde. The distribution of
different DNA contents was determined using a
FACScan flow cytometer (Becton Dickinson, San Jose,
CA, USA). In each sample, 10,000 ungated events were
acquired. Analysis of cell cycle distribution (including
apoptosis) was performed (Becton Dickinson).
Statistical analyses were performed with Student’s
t-tests for paired and unpaired data. Unless specified,
all results are presented as the mean ±standard error.
IL-1 is used throughout the paper to denote IL-1a.
Results
IL-1 increases ceramide levels in IEC
IL-1 has been shown to play a role in stimulating
sphingomyelin breakdown. IEC were treated with
different concentrations of IL-1 for various time
periods and the levels of ceramide measured. Basal
ceramide levels in Mode-K and T-84 cells were 2.6 ±
0.8 and 3.0 ± 0.1 pmol/nmol of phosphate, respec-
tively. These levels were increased significantly with
treatment of the cells with [IL-1] = 30 ng/ml, and
peaked in increase at 4 and 1 h for Mode-K cells and
T-84 cells, respectively (Table 1). The maximum
increase in ceramide accumulation was similar for the
two cell lines. However, maximum levels of ceramide
were reached at different rates. Ceramide increase
was also dependent on the concentration of IL-1 used.
The maximum increase in ceramide levels was
reached at [IL-1] = 10–30 ng/ml for both cell lines.
The effect of ceramide and IL-1 on IEC
apoptosis
Ceramide has been directly linked to the induction of
cytokine-mediated apoptosis.22 To test whether IL-1
IL-1 increases ceramide without inducing apoptosis
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Table 1. Effect of interleukin-1 (IL-1) on ceramide production
in intestinal epithelial cells (IEC)a
Time (h) Ceramide levels (pmol/nmol)
Mode-K cells (n = 6) T-84 cells (n = 3)
0 2.6 ± 0.8 3.0 ± 0.1
1 N.D. 10.4 ± 0.6*
2 6.7 ± 1.2* 9.2 ± 1.0*
4 10.4 ± 1.3* 7.7 ± 0.5*
6 6.5 ± 1.2* 3.2 ± 0.04
12 6.3 ± 1.3* 3.0 ± 0.15
Data presented as mean ± standard error.
a Ceramide levels in IEC treated with IL-1 (30 ng/ml) for different time
periods.
*p < 0.05, p value represents the comparison of the effect of IL-1b on
ceramide production as compared with untreated cells.
causes apoptosis, IEC were treated with IL-1
(10–30 ng/ml), with ceramide (10–30mM), or with a
combination of both ceramide and IL-1 at different
concentrations. In Mode-K cells, IL-1 did not increase
the number of apoptotic cells measured at 24 h;
neither did ceramide or their combination in Mode-K
cells (Fig. 1). Similarly, no increase in apoptosis was
observed in T-84 cells as assessed by trypan blue
exclusion assay (Table 2).
In contrast, apoptosis was induced by treatment of
the IEC with hydrogen peroxide, exposure to g-irra-
diation or UV-irradiation (to test whether the
p53-dependent apoptotic pathway is functional in
these cells), or camptothecin (an example is illus-
trated in Fig. 2). These treatments resulted in
increased apoptosis as measured by annexin FITC
fluorescence using flow cytometry or by Hoechst
staining using fluorescence microscopy. This indi-
cates that IL-1 and/or ceramide treatment did not
induce apoptosis in IEC, although the cells are
capable of undergoing apoptosis as observed by other
test agents or treatments.
We have reported recently that IL-1 induces the
expression of COX-2 in IEC,6 through ceramide.
Increased COX-2 levels have been associated with
inhibition of apoptosis through increasing bcl-2 pro-
tein expression.10 Pre-treatment of Mode-K cells with
the COX-2 inhibitor (500 nM) L-745,337 and then
treatment with ceramide resulted in a significant
increase in apoptosis as assessed by trypan blue
exclusion assay (Table 3), which is in accordance with
what has been observed in rat intestinal epithelial
cells.10
The effect of ceramide and IL-1 on apoptosis
regulating proteins
We examined the level of expression of the major
cellular regulators of apoptosis that include bcl-2, bcl-
x and bax by Western blot analysis. In control Mode-K
cells, there was constitutive expression of all three
proteins (Fig. 3). The addition of IL-1 resulted in a
sharp decrease in bax expression 2 h post treatment,
was significantly decreased 6 h after treatment and
was completely abolished by 24 h (Fig. 3A). Ceramide
treatment as well as a combination of ceramide and IL-
1 caused an effect similar to that of IL-1 alone.
In contrast to bax downregulation, bcl-2 expression
was significantly increased by treatment of the cells
with IL-1 and/or ceramide (Fig. 3), while bcl-x
expression was not modified (data not shown). These
results suggest that IL-1 exerts its effect through
ceramide accumulation to decrease the levels of pro-
apoptotic factors and to increase anti-apoptotic pro-
teins, hence shifting from the apoptotic pathway to
increasing the production of eicosanoids as was
observed earlier.7 Further evidence that IL-1 or
ceramide treatment did not induce apoptosis in Mode-
K cells is that neither the level or the integrity of PARP
enzyme was changed (data not shown).
F.R. Homaidan et al.
42 Mediators of Inflammation · Vol 11 · 2002
FIG. 1. The effect of ceramide and IL-1, and their combina-
tion, on inducing apoptosis in Mode-K cells measured 24 h
after treatment (n = 4). Apoptosis was measured using
Annexin-V-Flous kit and cells wereanalyzed by flow cyto-
metry. IL-1 and/or ceramide did not increase the apoptotic
index in any of the treatments.
FIG. 2. Ceramide had no effect on apoptosis in Mode-K cells (C), although cells did undergo apoptosis when exposed to
ultraviolet rays (B) as compared with a time control (A).
Table 2. Effect of interleukin-1 treatment on T-84 cellsa
Time (h) % Dead cells
(mean ± standard error)
0 1.04 ± 0.00
1 0.79 ± 0.01
2 1.53 ± 0.01
4 1.65 ± 0.48
12 1.63 ± 0.93
24 1.89 ± 1.08
a T-84 cells were treated with interleukin-1 (30 ng/ml) for
different time periods. Cell viability was measured using
the trypan blue exclusion assay.
The effect of ceramide and IL-1 on p53 and p21
protein levels
The levels of p53 and p21 were examined in cells
treated with IL-1 or ceramide at different concentra-
tions and different time periods. None of the treat-
ments had any effect on p53 levels, as assessed by
Western blotting assays (Fig. 4). However, p21 levels
were decreased significantly within 1 h after treat-
ment with either IL-1 or ceramide and peaked at 4 h,
then returned to basal levels after 24 h.
The effect of ceramide and IL-1 on cell cycle
To investigate whether ceramide and/or IL-1 affect
cell proliferation, cell cycle analysis was performed by
measuring DNA content as described in ‘Materials and
methods’. No major modification of the distribution
of the different cell cycle phases (pre-G0, G0/G1, S
and G2/M phases) was observed except for a moder-
ate increase in the percentage of cells in the G2/M
phase in IL-1 and/or ceramide-treated cells, resulting
in a decrease in the percentage of cells in the G0/G1
phases (Fig. 5).
Cell cycle analysis was also employed for the
evaluation of apoptosis. The percentages of cells in
the pre-G0/G1 phase (representing, at least in part,
apoptotic cells) in control as well as in treated cells
were not different (3.25 ± 0.2% in control untreated
cells versus 4.95 ± 2.4 in 30 ng/ml of IL-1-treated cells;
not significant). Thus, the induction of apoptosis by
these treatments was ruled out.
Discussion
IL-1, a pro-inflammatory cytokine, is produced and
secreted by inflammatory cells and other cell types in
response to a variety of stimuli. It is involved in many
inflammatory responses and is a potent inducer of
arachidonic acid mobilization and its metabolism to
prostaglandins and other eicosanoids, a hallmark of
inflammatory response. Several second messengers
have been shown to mediate the effects of this
cytokine. In intestinal epithelial cells, we have shown
that IL-1 elicits its effects mainly through activating
phospholipid messengers. It increases phospholipase
A2 (PLA2) activity,
23 and increases the expression of
PLA2-activating protein and the enzyme COX-2.
6,7
These effects lead to increased levels of PGE2 and to
a subsequent increase in Cl– secretion.24 Bioactive
lipids, generated in response to activation of various
lipases, serve as intracellular and extracellular media-
tors in cell signaling. They play important roles in a
variety of processes involving cell–cell communica-
tion, inflammation, host-defense mechanisms, and in
ischemia reperfusion. Ceramide, which is generated
from SM by the action of the ubiquitous enzyme
sphingomyelinase (SMase), serves as an important
IL-1 increases ceramide without inducing apoptosis
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Table 3. Percentage of apoptosis in Mode-K cells
Treatment % Dead cells
(mean ± standard error)a
nb
Control untreated cells 4.6 ± 0.1 6
L-745,337c (500 nM), 24 h treatment 4.3 ± 0.1 4
Ceramide (30mM), 24 h treatment 4.3 ± 0.5 6
L-745,337c (500 nM), pre-treatment for 1 h + ceramide (30mM), 24 h treatment 11.6 ± 1.4 4
H2O2 (1 mM), 2 h treatment 41.0 ± 10.0 6
a Mode-K cell viability was measured using the trypan blue exclusion assay.
b Number of experiments.
c COX-2 inhibitor used, L-745,337 (5-methanesulfonamide-6-(2,4-difluorothiophenyl)-1-indanone) .
FIG. 3. A representative Western blot (n = 5) showing the
effect of IL-1 (30 ng/ml) and ceramide (30mM) on the levels of
protein regulators of apoptosis. (A) Both IL-1 and ceramide
caused a sharp decrease in bax protein levels 1 h after
treatment, and bax was abolished by 24 h. (B) Both IL-1 and
ceramide caused an increase in bcl-2 levels 4 h after
treatment.
FIG. 4. A representative Western blot (n = 4) showing: (A) the
lack of effect of IEC treatment by IL-1 (30 ng/ml) and/or
ceramide on p53 levels, and (B) the decrease in p21 levels by
IL-1 and/or ceramide.
pleiotropic signal transducer in apoptosis as well as in
cell proliferation and differentiation.4,5,25 All sphingo-
lipids contain ceramide as the basic hydrophylic
component that is released by activated SMase. SMase
can be activated by a variety of extracellular signals
and stimulants including TNF-a, g-interferon, IL-1 and
ionizing radiation. The nature of ceramide-mediated
signaling suggests that the SM pathway may link
downstream to a variety of effector systems. Evidence
suggest that ceramide play a role in signaling of both
the pro-inflammatory and apoptotic effects of TNF-
a.26 Ceramide also stimulates cytokine production in
some cell types, suggesting a role in extracellular
signaling via the cytokine network.27 A connection
between cytokine signaling, inflammation and the SM
pathway have also been suggested4 by virtue of the
effects of ceramide on the induction of PGE2 produc-
tion. Ceramide has also been implicated in increasing
PLA2 activity and stimulating the transcription of
cyclooxygenase in inflammation, leading to increased
production of PGE2.
4,28 However, we have shown
recently that ceramide increased the production of
PGE2 in intestinal epithelial cells through inducing
COX-2 synthesis without any effect on PLA2 activity.
6
The generation of eicosanoids such as PGE2 repre-
sents an important signaling system utilized by many
cytokine/growth factor receptors. Hence, it appears
that there is a cross-talk between receptor signaling
through activation of the SM pathway and eicosanoid
production.
Ceramide has also been implicated in cytokine-
mediated apoptosis.22,29 This was supported by the
finding that apoptosis was induced by exogenous
bacterial SMase, which cleaves SM to result in
ceramide. In the present study, we show that neither
ceramide nor IL-1 increase IEC apoptosis. These data
suggest that ceramide does not activate the apoptotic
pathway, but rather feeds into the eicosanoid meta-
bolic pathway. Similar findings have been reported
recently in human leukemic cells30 and in rat alveolar
cells.31 Exogenous ceramide failed to trigger apopto-
sis in human myelogenous leukemic cells30 although
TNF-a-induced apoptosis was blocked by a sphingo-
myelinase inhibitor. This indicates that ceramide was
necessary but not sufficient for TNF-a-induced apop-
tosis. Mallampalli et al. also observed that ceramide
resulting from TNF-a activation of SM hydrolysis
might activate the mitogen-activated protein kinase
and nuclear factor (NF)-kB pathways without increas-
ing programmed cell death in alveolar type II epithe-
lial cells.31
In addition to the tightly regulated pro-apoptotic
mechanisms, mammalian cells also operate anti-
apoptotic mechanisms to constrain apoptosis. These
include the bcl-2 system,32–34 loss of p53 activity,35,36
activation of NF-kB,37,38 and activation of the 1,2-dia-
cylglycerol-protein kinase C signaling system.39,40
These anti-apoptopic systems and the pro-apoptotic
systems are both subject to regulation. While origi-
nally bcl-2-related proteins were reported to confer
anti-apoptotic protection, it was subsequently shown
that some members of this family serve as pro-
apoptotic factors.32,34 bcl-2 and bcl-x are the main
members of this family that inhibit apoptosis, while
bax and bad are the two best known pro-apoptotic
factors. Prolonged cell survival with resistance to
apoptosis can be a primary oncogenic event. Evi-
dence has emerged that a principal contribution from
the loss of p53 function is the elimination of a death
pathway.41,42 In select settings, stimuli that induce
p53 result in the expression of bax.43 In the present
study, p53 levels as well as bcl-x were not affected by
treatment of the cells by IL-1 and/or ceramide, while
bax levels were decreased significantly and bcl-2
levels were increased, further supporting the finding
that ceramide does not lead the cells into the
apoptotic pathway. Furthermore, the increased pro-
liferation observed in treated intestinal epithelial cells
correlated with the decreased protein levels of the
cyclin-dependent kinase inhibitor p21 reported in this
study.
Recent studies have shown that induction of PGE2
and COX-2 levels inhibit apoptosis in IEC44 through
inducing bcl-2 expression but with no effect on bax
expression. This could explain the lack of apoptosis in
Mode-K cells since we have shown that ceramide and
IL-1 induce COX-2 and/or PLA2, both leading to
increased levels of PGE2.
6
These data suggest that while ceramide might still
initiate the upstream apoptotic pathway, it does not
commit the cell to the death process. The bcl-2
protein family can still reverse the process at multiple
checkpoints along the apoptotic-signaling pathway.
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FIG. 5. Effects of IL-1 (30 ng/ml) and ceramide (30mM) on the
cell cycle distribution of IEC after 24h of treatment. Histo-
gram-related nuclear DNA contents were measured by flow
cytometry as described in ‘Materials and methods’. The sum
of G0/G1 and S–G2/M phases is normalized to 100% (n = 3).
Apoptosis plays a major role in the pathogenesis of
disease and its management. Improved understanding
of mechanisms of pro-apoptosis and anti-apoptosis
and their coordinated function may yield opportun-
ities for pharmacological interventions in human
disease with important potentials for clinical applica-
tions. The anti-apoptotic effects caused by IL-1 and
ceramide suggest a role for them in IBD and propose
a possible mechanism for the enhanced tumorigenic
activity of intestinal epithelial cells in IBD patients.
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